Abstract:Introduction: Hypoxic-ischemic encephalopathy (HIE) is one of the leading causes of death and neurological disability with limited options for treatment in neonates, children and adults worldwide. The pathogenesis and treatment of white matter (WM) injury in adult patients with HIE remains largely elusive. Methods: Sixty male Sprague-Dawley rats were randomly divided into control group, sham-operated group (HBO treatment 6 days after sham operation), and Hypoxia-ischemia (HI) induced brain damage group (receiving left carotid arteries ligation + hypoxia treatment), 1.5ATA hyperbaric oxygen group (HI + 1.5ATA HBOT) and 2.5ATA HBOT group (HI + 2.5ATA HBOT). All the rats were evaluated by water maze before operation, and 6 days after operation, and the function of learning and memory was evaluated; Demyelination in the hippocampus and prefrontal cortex was observed by Luxol fast blue staining (LFB) and MBP immunostaining; the number of Myelin Oligodendrocyte Glycoprotein (MOG),glial fibrillary acidic protein (GFAP), ionic calcium-binding adaptor (Iba-1) and NG2 positive cells in the hippocampus and prefrontal cortex were determined by immunofluorescence staining. The expression of interleukin-1β (IL-1β), IL-6 and tumor necrosis factor (TNF-α), Hypoxia Inducible Factor 1 Subunit Alpha (HIF1-α) and Superoxide dismutase (SOD) in brain and serum of rats were measured by Western Blot method and Enzyme linked immunosorbent assay (ELISA). Results: Compared with those in the normal control group and sham-operated group, in the HI group, the learning and memory abilities of rats were significantly decreased (P < 0.05), the intensity of LFB and MBP immunostaining in hippocampus and prefrontal cortex was significantly decreased (P < 0.05); the number of MOG positive oligodendrocytes (OLs) significantly decreased (P < 0.05), whereas the number of Iba-1, GFAP, NG2 positive microglias, astrocytes and oligodendrocyte precursors (OPCs) was increased (P < 0.05); the level of IL-1β, IL-6, TNF-α and HIF-1a in brain and serum were significantly increased (P < 0.05), whereas SOD was significantly decreased in brain and increased in serum. Compared with those in the HI group, in both 1.5ATA and 2.5ATA HBOT group, the learning and memory abilities were significantly increased (P < 0.05); the intensity of LFB and MBP immunostaining in the hippocampus and prefrontal cortex was significantly increased (P < 0.05); the number of MOG positive OLs significantly increased (P < 0.05); the number of Iba-1, GFAP, NG2 positive microglias, astrocytes and OPCs was decreased (P < 0.05); the level of IL-1β, IL-6, TNF-α and HIF-1a in brain and serum were significantly decreased (P < 0.05); the level of SOD was significantly increased in brain and decreased in serum. Morever, compared with those in the 1.5ATA group, 2.5ATA provided better treatment results (P < 0.05). Conclusion: In the present study, we demonstrated the mechanism of different pressure HBOT on HI induced brain injury from three levels: (1) On a tissue level, HBOT protects against HI induced myelin injury; (2) On a cellular level, HBOT attenuates HI-induced OL loss, suppresss the reactive activation of astrocyte and microglia, and may promote OPC to differentiate into OL; (3) On a molecular level, HBOT inhibites neuroinflammation, and balances oxidative damage and antioxidant capacity. Among the above effects, 2.5ATA HBOT is better than 1.5ATA HBOT. Ongoing research will continue to seek out the signalling pathways and molecules mechanisms on different pressure of HBOT-related myelin protection, and possibly expand suitable HBOT use in adult HIE clinically.

Hyperbaric Oxygen on the expression of ECM-related Molecules of Intracephalic Angiogenesis in rats with Int racerebral

Therapeutic Effect Analysis of HBO for Diving Decompression Sickness: a Report of 56 Cases

Hyperbaric Oxygen Therapy in Liver Diseases

Cia_a_306255 1173..1184

Effect of Hyperbaric Oxygen Treatment on Mitochondrial Free Radicals Af Ter Transient Focal Cerebral Ischemia in Rats

Involvement of the Mitochondrial ATP-sensitive Potassium Channel in the Neuroprotective Effect of Hyperbaric Oxygenation after Cerebral Ischemia.

Utilizing Cerebral Perfusion Scan and Diffusion-tensor MR Imaging to Evaluate the Effect of Hyperbaric Oxygen Therapy in Carbon Monoxide-induced Delayed Neuropsychiatric Seqeulae- A Case Report and Literature Review

Neuroprotection of Hyperbaric Oxygen Treatment for Traumatic Brain Injury Involving Autophagy Pathway in Rats

EFFECT OF HYPERBARIC OXYGENATION TREATMENT ON THE APOPTOTIC CELL DEATH PATHWAY AFTER TRANSIENT FOCAL CEREBRAL ISCHEMIA

Influence of hyperbaric oxygen therapy-specialized care on limb motor function and mental state of cerebral infarction patients with hemiplegia

EFFECTS OF HYPERBARIC OXYGEN THERAPY ON INTESTINAL ISCHEMIA-REPERFUSION AND ITS MECHANISM

Hyperbaric oxygen for severe traumatic brain injury: a randomized trial

Study of hyperbaric oxygen combined with movement imagination and cabin movement for treatment of patients with cerebral infarction complicated with hemiplegia

Hyperbaric Oxygen in Treatment of Neurosurgery Related Diseases

Efficacy and safety of hyperbaric oxygen therapy in acute ischaemic stroke: a systematic review and meta-analysis

Effect of Hyperbaric oxygen on myelin injury and repair after hypoxic-ischemic brain damage in adult rat

Effect of Hyperbaric Oxygen Combined with Ganglion Glycosides on Thrombin, Serum Myelin Basic Protein and D-dimer in Patients with Intracerebral Hemorrhage

Hyperbaric Oxygen in Combination with Epigallocatechin-3-Gallate Synergistically Enhance Recovery from Spinal Cord Injury in Rats

Therapeutic Strategies for Poststroke Neurological Behavior: from Molecular to Cellular

Ther Apeutic Effect of Hyperbaric Oxygen on Postoperative Brain Re-Expansion in Elderly Patients with Bilateral Chronic Subdural Hematoma at Middle and High Altitude Areas

The Protection Effect and Mechanism of Hyperbaric Oxygen Therapy in Rat Brain with Traumatic Injury.